RESUMO
Neospora caninum is an obligate intracellular parasite related to cases of abortion and fertility impairment in cattle. The control of the parasite still lacks an effective protective strategy and the understanding of key mechanisms for host infection might be crucial for identification of specific targets. There are many proteins related to important mechanisms in the host cell infection cycle such as adhesion, invasion, proliferation and immune evasion. The surface proteins, especially SRS (Surface Antigen Glycoprotein - Related Sequences), have been demonstrated to have a pivotal role in the adhesion and invasion processes, making them potential anti-parasite targets. However, several predicted surface proteins were not described concerning their function and importance in the parasite life cycle. As such, a novel SRS protein, NcSRS57, was described. NcSRS57 antiserum was used to detect SRS proteins by immunofluorescence in parasites treated or not with phosphatidylinositol-specific phospholipase C (PI-PLC). The treatment with PI-PLC also allowed the identification of NcSRS29B and NcSRS29C, which were the most abundant SRS proteins in the soluble fraction. Our data indicated that SRS proteins in N. caninum shared a high level of sequence similarity and were susceptible to PI-PLC. In addition, the description of the SRS members, regarding abundance, function and immunogenicity will be useful in guiding specific methods to control the mechanism of adhesion and invasion mediated by these surface proteins.
Assuntos
Antígenos de Protozoários/metabolismo , Antígenos de Superfície/metabolismo , Neospora/química , Fosfoinositídeo Fosfolipase C/farmacologia , Proteínas de Protozoários/metabolismo , Animais , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Antígenos de Superfície/genética , Antígenos de Superfície/imunologia , Chlorocebus aethiops , Clonagem Molecular , DNA de Protozoário/isolamento & purificação , Eletroforese em Gel Bidimensional , Eletroforese em Gel de Poliacrilamida , Soros Imunes/imunologia , Soros Imunes/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Confocal , Neospora/efeitos dos fármacos , Neospora/genética , Neospora/imunologia , Fosfoinositídeo Fosfolipase C/metabolismo , Proteínas de Protozoários/genética , Proteínas de Protozoários/imunologia , Espectrometria de Massas em Tandem , Fosfolipases Tipo C/metabolismo , Fosfolipases Tipo C/farmacologia , Células VeroRESUMO
Glycosylphosphatidylinositol-anchored proteins are abundant on the surface of pathogenic protozoans and might play an important role for parasite survival. In the present work, the relevance of GPI-anchored proteins for erythrocyte invasion of the cattle hemoparasite Babesia bovis was studied. We show that cleavage of GPI-anchored antigens from the merozoite parasite stage by phosphatidylinositol-specific phospholipase C abolished invasion of erythrocytes demonstrating the importance of this class of molecules for parasite propagation. In addition, the repertoire of GPI-anchored proteins of B. bovis was predicted with high fidelity by searching its genome with available web-based bioinformatic tools. Altogether 17 GPI-anchored proteins were identified, 5 of which represent the already characterized variable merozoite surface antigens (VMSAs). Fifteen of the identified GPI-anchored proteins contain 2-26 amino acid repeats indicating that they are likely involved in functions of recognition, adhesion, or transport. Repeats were found to contain an increased frequency of proline, indicative of unstructured regions; and were estimated to be 3.21 times more hydrophilic than non-repeat regions. This suggests that they might represent eminent antibody epitopes. The majority of the putative GPI-anchored antigens reported in this work have so far remained unnoticed, though they may represent potential candidates for inclusion in a subunit vaccine.
Assuntos
Antígenos de Protozoários/imunologia , Babesia bovis/genética , Babesiose/parasitologia , Doenças dos Bovinos/parasitologia , Proteínas Ligadas por GPI/metabolismo , Genoma de Protozoário/genética , Animais , Antígenos de Superfície/imunologia , Babesia bovis/imunologia , Babesia bovis/fisiologia , Babesiose/imunologia , Bovinos , Doenças dos Bovinos/imunologia , Biologia Computacional , Eritrócitos/parasitologia , Proteínas Ligadas por GPI/genética , Proteínas Ligadas por GPI/imunologia , Glicosilfosfatidilinositóis/metabolismo , Merozoítos , Família Multigênica , Proteoma , Fosfolipases Tipo C/farmacologiaRESUMO
Clostridium perfringens phospholipase C (CpPLC), also called α-toxin, is the most toxic extracellular enzyme produced by this bacteria and is essential for virulence in gas gangrene. At lytic concentrations, CpPLC causes membrane disruption, whereas at sublytic concentrations this toxin causes oxidative stress and activates the MEK/ERK pathway, which contributes to its cytotoxic and myotoxic effects. In the present work, the role of PKC, ERK 1/2 and NFκB signalling pathways in ROS generation induced by CpPLC and their contribution to CpPLC-induced cytotoxicity was evaluated. The results demonstrate that CpPLC induces ROS production through PKC, MEK/ERK and NFκB pathways, the latter being activated by the MEK/ERK signalling cascade. Inhibition of either of these signalling pathways prevents CpPLC's cytotoxic effect. In addition, it was demonstrated that NFκB inhibition leads to a significant reduction in the myotoxicity induced by intramuscular injection of CpPLC in mice. Understanding the role of these signalling pathways could lead towards developing rational therapeutic strategies aimed to reduce cell death during a clostridialmyonecrosis.
Assuntos
Toxinas Bacterianas/farmacologia , Proteínas de Ligação ao Cálcio/farmacologia , MAP Quinase Quinase 1/metabolismo , Melanoma/patologia , Músculo Esquelético/patologia , NF-kappa B/metabolismo , Proteína Quinase C/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Fosfolipases Tipo C/farmacologia , Animais , Western Blotting , Células CHO , Proliferação de Células/efeitos dos fármacos , Cricetulus , Melanoma/tratamento farmacológico , Melanoma/metabolismo , Camundongos , Músculo Esquelético/metabolismo , Transdução de Sinais , Células Tumorais CultivadasRESUMO
In previous studies, we demonstrated biphasic purinergic effects on prolactin (PRL) secretion stimulated by an adenosine A2 agonist. In the present study, we investigated the role of the activation of adenosine A1 receptors by (R)-N6-(2-phenylisopropyl)adenosine (R-PIA) at the pituitary level in in vitro PRL secretion. Hemipituitaries (one per cuvette in five replicates) from adult male rats were incubated. Administration of R-PIA (0.001, 0.01, 0.1, 1, and 10 microM) induced a reduction of PRL secretion into the medium in a U-shaped dose-response curve. The maximal reduction was obtained with 0.1 microM R-PIA (mean +/- SEM, 36.01 +/- 5.53 ng/mg tissue weight (t.w.)) treatment compared to control (264.56 +/- 15.46 ng/mg t.w.). R-PIA inhibition (0.01 microM = 141.97 +/- 15.79 vs control = 244.77 +/- 13.79 ng/mg t.w.) of PRL release was blocked by 1 microM cyclopentyltheophylline, a specific A1 receptor antagonist (1 microM = 212.360 +/- 26.560 ng/mg t.w.), whereas cyclopentyltheophylline alone (0.01, 0.1, 1 microM) had no effect. R-PIA (0.001, 0.01, 0.1, 1 microM) produced inhibition of PRL secretion stimulated by both phospholipase C (0.5 IU/mL; 977.44 +/- 76.17 ng/mg t.w.) and dibutyryl cAMP (1 mM; 415.93 +/- 37.66 ng/mg t.w.) with nadir established at the dose of 0.1 microM (225.55 +/- 71.42 and 201.9 +/- 19.08 ng/mg t.w., respectively). Similarly, R-PIA (0.01 microM) decreased (242.00 +/- 24.00 ng/mg t.w.) the PRL secretion stimulated by cholera toxin (0.5 mg/mL; 1050.00 +/- 70.00 ng/mg t.w.). In contrast, R-PIA had no effect (468.00 +/- 34.00 ng/mg t.w.) on PRL secretion stimulation by pertussis toxin (0.5 mg/mL; 430.00 +/- 26.00 ng/mg t.w.). These results suggest that inhibition of PRL secretion after A1 receptor activation by R-PIA is mediated by a Gi protein-dependent mechanism.
Assuntos
Adenosina/análogos & derivados , Adeno-Hipófise/efeitos dos fármacos , Prolactina/metabolismo , Receptor A1 de Adenosina/metabolismo , Transdução de Sinais , Adenosina/farmacologia , Animais , Toxina da Cólera/farmacologia , CMP Cíclico/análogos & derivados , CMP Cíclico/farmacologia , Relação Dose-Resposta a Droga , Masculino , Toxina Pertussis/farmacologia , Adeno-Hipófise/metabolismo , Radioimunoensaio , Ratos , Ratos Wistar , Fosfolipases Tipo C/farmacologiaRESUMO
In previous studies, we demonstrated biphasic purinergic effects on prolactin (PRL) secretion stimulated by an adenosine A2 agonist. In the present study, we investigated the role of the activation of adenosine A1 receptors by (R)-N6-(2-phenylisopropyl)adenosine (R-PIA) at the pituitary level in in vitro PRL secretion. Hemipituitaries (one per cuvette in five replicates) from adult male rats were incubated. Administration of R-PIA (0.001, 0.01, 0.1, 1, and 10 æM) induced a reduction of PRL secretion into the medium in a U-shaped dose-response curve. The maximal reduction was obtained with 0.1 æM R-PIA (mean ± SEM, 36.01 ± 5.53 ng/mg tissue weight (t.w.)) treatment compared to control (264.56 ± 15.46 ng/mg t.w.). R-PIA inhibition (0.01 æM = 141.97 ± 15.79 vs control = 244.77 ± 13.79 ng/mg t.w.) of PRL release was blocked by 1 æM cyclopentyltheophylline, a specific A1 receptor antagonist (1 æM = 212.360 ± 26.560 ng/mg t.w.), whereas cyclopentyltheophylline alone (0.01, 0.1, 1 æM) had no effect. R-PIA (0.001, 0.01, 0.1, 1 æM) produced inhibition of PRL secretion stimulated by both phospholipase C (0.5 IU/mL; 977.44 ± 76.17 ng/mg t.w.) and dibutyryl cAMP (1 mM; 415.93 ± 37.66 ng/mg t.w.) with nadir established at the dose of 0.1 æM (225.55 ± 71.42 and 201.9 ± 19.08 ng/mg t.w., respectively). Similarly, R-PIA (0.01 æM) decreased (242.00 ± 24.00 ng/mg t.w.) the PRL secretion stimulated by cholera toxin (0.5 mg/mL; 1050.00 ± 70.00 ng/mg t.w.). In contrast, R-PIA had no effect (468.00 ± 34.00 ng/mg t.w.) on PRL secretion stimulation by pertussis toxin (0.5 mg/mL; 430.00 ± 26.00 ng/mg t.w.). These results suggest that inhibition of PRL secretion after A1 receptor activation by R-PIA is mediated by a Gi protein-dependent mechanism.
Assuntos
Animais , Masculino , Ratos , Adenosina/análogos & derivados , Adenosina/farmacologia , Adeno-Hipófise , Prolactina , Receptor A1 de Adenosina/metabolismo , Transdução de Sinais , Toxina da Cólera/farmacologia , CMP Cíclico/farmacologia , Relação Dose-Resposta a Droga , Toxina Pertussis/farmacologia , Fosfolipases Tipo C/farmacologia , Adeno-Hipófise/efeitos dos fármacos , Prolactina/efeitos dos fármacos , Radioimunoensaio , Ratos WistarRESUMO
The cell-associated and extracellular peptidases of Herpetomonas megaseliae grown in brain-heart infusion and in modified Roitman's complex media were analyzed by measuring peptidase activity on gelatin, casein and hemoglobin in zymograms. Casein was the best proteinaceous substrate for the peptidase detection on both growth conditions. However, no proteolytic activity was detected when hemoglobin was used. Our results showed that cellular cysteine peptidase (115-100, 40 and 35 kDa) and metallopeptidase (70 and 60 kDa) activities were detected on both media in casein and gelatin zymograms. Additionally, the use of casein in the gel revealed a distinct acidic metallopeptidase of 50 kDa when the parasite was cultured in the modified Roitman's complex medium. Irrespective of the culture medium composition, H. megaseliae released metallopeptidases exclusively in the extracellular environment. The presence of gp63-like molecules on the H. megaseliae surface was shown by flow cytometry using anti-gp63 antibody raised against recombinant gp63 from Leishmania mexicana. The pre-treatment of parasites with phospholipase C reduced the number of gp63-positive cells, suggesting that these molecules were glycosylphosphatidylinositol-anchored to the surface. Additionally, the supernatant obtained from phospholipase C-treated cells and probed with anti-cross-reacting determinant confirmed that at least a 52 kDa gp63-like molecule is glycosylphosphatidylinositol-anchored. Furthermore, we assessed a possible function for the gp63-like molecules in H. megaseliae on the interaction with explanted guts of its original host, Megaselia scalaris, and with an experimental model employing Aedes aegypti. Parasites pre-treated with either anti-gp63 antibody or phospholipase C showed a significant reduction in the adhesion to M. scalaris and A. aegypti guts. Similarly, the pre-treatment of the explanted guts with purified gp63 diminished the interaction process. Collectively, these results corroborate the ubiquitous existence of gp63 homologues in insect trypanosomatids and the potential adhesion of these molecules to invertebrate host tissues.
Assuntos
Metaloendopeptidases/fisiologia , Peptídeo Hidrolases/fisiologia , Trypanosomatina/fisiologia , Aedes/parasitologia , Animais , Adesão Celular/fisiologia , Meios de Cultura , Dípteros/parasitologia , Citometria de Fluxo/métodos , Interações Hospedeiro-Parasita , Insetos Vetores/parasitologia , Intestinos/parasitologia , Metaloendopeptidases/metabolismo , Peptídeo Hidrolases/metabolismo , Trypanosomatina/efeitos dos fármacos , Trypanosomatina/metabolismo , Fosfolipases Tipo C/farmacologiaRESUMO
We have analyzed the effects of exogenous phospholipase C (PLC) on the cell-surface polypeptides and proteinases of Herpetomonas samuelpessoai grown in chemically defined conditions by SDS-PAGE gels. Live parasites treated with PLC released into the extracellular medium a complex profile of glycosylphosphatidylinositol (GPI)-anchored polypeptides ranging from 15 to 100 kDa, some of them with proteolytic activity. Two major metalloproteinases with apparent molecular masses of 63 and 115 kDa were observed after PLC hydrolysis. Interestingly, only the PLC-released soluble form of the 115-kDa metalloenzyme, and not the membrane-anchored form, displayed proteolytic activity, demonstrating that cleavage of the GPI anchor can lead to enzymatic activation.
Assuntos
Membrana Celular/enzimologia , Endopeptidases/metabolismo , Glicosilfosfatidilinositóis/metabolismo , Trypanosomatina/enzimologia , Fosfolipases Tipo C/farmacologia , Animais , Membrana Celular/metabolismo , Meios de Cultura , Ativação Enzimática , Trypanosomatina/efeitos dos fármacos , Trypanosomatina/ultraestrutura , Fosfolipases Tipo C/metabolismoRESUMO
To test for a role for the cellular prion protein (PrP(c)) in cell death, we used a PrP(c)-binding peptide. Retinal explants from neonatal rats or mice were kept in vitro for 24 h, and anisomycin (ANI) was used to induce apoptosis. The peptide activated both cAMP/protein kinase A (PKA) and Erk pathways, and partially prevented cell death induced by ANI in explants from wild-type rodents, but not from PrP(c)-null mice. Neuroprotection was abolished by treatment with phosphatidylinositol-specific phospholipase C, with human peptide 106-126, with certain antibodies to PrP(c) or with a PKA inhibitor, but not with a MEK/Erk inhibitor. In contrast, antibodies to PrP(c) that increased cAMP also induced neuroprotection. Thus, engagement of PrP(c) transduces neuroprotective signals through a cAMP/PKA-dependent pathway. PrP(c) may function as a trophic receptor, the activation of which leads to a neuroprotective state.
Assuntos
Anisomicina/farmacologia , Apoptose/efeitos dos fármacos , AMP Cíclico/análogos & derivados , AMP Cíclico/fisiologia , Proteínas do Olho/fisiologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Proteínas PrPC/metabolismo , Retina/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Anisomicina/antagonistas & inibidores , Anticorpos Monoclonais/farmacologia , Apoptose/fisiologia , Colforsina/farmacologia , AMP Cíclico/farmacologia , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Proteínas Quinases Dependentes de AMP Cíclico/efeitos dos fármacos , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Proteínas do Olho/antagonistas & inibidores , Proteínas do Olho/biossíntese , Proteínas do Olho/imunologia , Flavonoides/farmacologia , Regulação da Expressão Gênica no Desenvolvimento , Soros Imunes , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteína Quinase 1 Ativada por Mitógeno/efeitos dos fármacos , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno , Proteínas Quinases Ativadas por Mitógeno/efeitos dos fármacos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Técnicas de Cultura de Órgãos , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/metabolismo , Fosfatidilinositol Diacilglicerol-Liase , Fosfoinositídeo Fosfolipase C , Fosforilação , Proteínas PrPC/química , Processamento de Proteína Pós-Traducional , Ratos , Ratos Endogâmicos , Retina/metabolismo , Tionucleotídeos/farmacologia , Fosfolipases Tipo C/farmacologiaRESUMO
The diacylglycerol (DAG) signal generated from membrane phospholipids by hormone-activated phospholipases is attenuated by mechanisms that include lipolysis or phospholipid resynthesis. To determine whether the DAG signal might also be terminated by incorporation of DAG into triacylglycerol (TAG), we studied the direct formation of TAG from endogenous DAG generated by bacterial phospholipase C (PLC). When Chinese hamster ovary (CHO) cells prelabeled with [(14)C]oleate were treated with PLC from Clostridium perfringens for 6 h, [(14)C]phospholipid decreased 15% and labeled TAG increased 60%. This transfer of (14)C label was even greater when the cells were simultaneously exposed to PLC and 100 microM oleic acid. PLC as well as oleate treatment concomitantly increased the TAG mass within the cell. Moreover, when phospholipids were prelabeled with [(3)H]glycerol, a subsequent increase in [(3)H]TAG indicated that an intact DAG moiety was channeled into the TAG structure. Incubating CHO cells with the diacylglycerol kinase inhibitor R59022 enhanced the formation of TAG from phospholipids hydrolyzed by PLC or by PLC in the presence of 100 microM oleate, but not by incubation with oleate alone, indicating that the DAG released from plasma membrane phospholipids does not require the formation of a phosphatidic acid precursor for TAG synthesis. Similarly, the diacylglycerol lipase inhibitor RHC 80267 did not alter TAG synthesis from plasma membrane DAG, further supporting direct incorporation of DAG into TAG. These studies indicate that DAG derived from plasma membrane phospholipid is largely used for TAG formation, and support the view that this mechanism can terminate DAG signals. The studies also suggest that a transport mechanism exists to move plasma membrane-derived DAG to the endoplasmic reticulum.-Igal, R. A., J. M. Caviglia, I. N. T. de Gómez Dumm, and R. A. Coleman. Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis. J. Lipid Res. 2001. 42: 88;-95.
Assuntos
Membrana Celular/metabolismo , Diglicerídeos/metabolismo , Triglicerídeos/biossíntese , Fosfolipases Tipo C/metabolismo , Aciltransferases/metabolismo , Animais , Transporte Biológico , Células CHO , Cricetinae , Diacilglicerol O-Aciltransferase , Retículo Endoplasmático/metabolismo , Traçadores Radioativos , Sistemas do Segundo Mensageiro/efeitos dos fármacos , Sistemas do Segundo Mensageiro/fisiologia , Fosfolipases Tipo C/farmacologiaRESUMO
We investigated the role of intracellular Mg(2+) (Mg(i)(2+)) on the ATP regulation of Na(+)/Ca(2+) exchanger in squid axons and bovine heart. In squid axons and nerve vesicles, the ATP-upregulated exchanger remains activated after removal of cytoplasmic Mg(2+), even in the absence of ATP. Rapid and complete deactivation of the ATP-stimulated exchange occurs upon readmission of Mg(i)(2+). At constant ATP concentration, the effect of intracellular Mg(2+) concentration ([Mg(2+)](i)) on the ATP regulation of exchanger is biphasic: activation at low [Mg(2+)](i), followed by deactivation as [Mg(2+)](i) is increased. No correlation was found between the above results and the levels of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P(2)] measured in nerve membrane vesicles. Incorporation of PtdIns(4,5)P(2) into membrane vesicles activates Na(+)/Ca(2+) exchange in mammalian heart but not in squid nerve. Moreover, an exogenous phosphatase prevents MgATP activation in squid nerves but not in mammalian heart. It is concluded that 1) Mg(i)(2+) is an essential cofactor for the deactivation part of ATP regulation of the exchanger and 2) the metabolic pathway of ATP upregulation of the Na(+)/Ca(2+) exchanger is different in mammalian heart and squid nerves.
Assuntos
Trifosfato de Adenosina/farmacologia , Decapodiformes/fisiologia , Membranas Intracelulares/metabolismo , Magnésio/fisiologia , Sistema Nervoso/metabolismo , Trocador de Sódio e Cálcio/metabolismo , Fosfatase Alcalina/farmacologia , Animais , Anticorpos/farmacologia , Axônios/metabolismo , Cálcio/metabolismo , Membrana Celular/metabolismo , Troca Iônica , Miocárdio/metabolismo , Fosfatidilinositol 4,5-Difosfato/imunologia , Fosfatidilinositol Diacilglicerol-Liase , Fosfatidilinositóis/metabolismo , Fosfolipases Tipo C/farmacologia , Regulação para CimaRESUMO
The action of reducing, oxidizing and thiol-alkylating agents on early steps of Junin virus (JV) multiplication in Vero cells was investigated. The presence of reducing agents during virus adsorption as well as incubation of viral particles with these compounds before infection enhanced JV infectivity. On the contrary, the thiol-alkylating agent 5,5' dithiobis (2-nitrobenzoic acid) and the oxidizing compound potassium periodate showed an inhibitory effect, suggesting that sulfhydryl groups, and certain sugar moieties of viral glycoproteins play an important role in the first steps of JV infection. Also enzymatic treatment of cell monolayers and addition of concanavalin A to cultures prior to infection suggest that cellular glycoproteins are involved in virus attachment.
Assuntos
Alquilantes/farmacologia , Vírus Junin/efeitos dos fármacos , Vírus Junin/fisiologia , Oxidantes/farmacologia , Substâncias Redutoras/farmacologia , Replicação Viral/efeitos dos fármacos , Animais , Chlorocebus aethiops , Concanavalina A/farmacologia , Ácido Ditionitrobenzoico/farmacologia , Ditiotreitol/farmacologia , Ficina/farmacologia , Glicoproteínas de Membrana/fisiologia , Mercaptoetanol/farmacologia , Ácido Periódico/farmacologia , Compostos de Potássio/farmacologia , Receptores Virais/efeitos dos fármacos , Receptores Virais/fisiologia , Reagentes de Sulfidrila/farmacologia , Fosfolipases Tipo C/farmacologia , Células Vero , Virulência/efeitos dos fármacos , Virulência/fisiologiaRESUMO
Both, culture-derived and metacyclic trypomastigotes of Trypanosoma cruzi shed a glycoprotein, the shed acute phase antigen, that is responsible for the trans-sialidase activity. In the present work the structure of the glycosylphosphatidylinositol membrane anchor of the trans-sialidase isolated from metacyclic forms was determined. Parasites were metabolically labelled with [9, 10(n)3H]-palmitic acid and the glycoprotein was purified by immunoprecipitation with a monoclonal antibody directed against the repetitive aminoacid sequence. Treatment of the glycoprotein with phosphatidylinositol phospholipase C (PI-PLC) from Bacillus thuringiensis rendered a lipid that comigrated in TLC with a standard of ceramide. No alkylglycerol was detected in contrast with the results previously obtained for the trans-sialidase isolated from culture-derived trypomastigotes where both lipids were found. Chemical and chromatographic analysis showed that the lipid moiety is palmitoyldihydrosphingosine with a minor amount of stearoyldihydrosphingosine. The glycan constituent of the glycosylphosphatidylinositol-anchor was analysed by nitrous acid deamination of the aqueous phase of the PI-PLC treatment, followed by reduction with NaBH4 and hydrolysis of the phosphodiester with aqueous hydrofluoric acid. A major oligosaccharide was obtained and enzymatic treatment with exoglycosidases and further chromatography in a high pH anion exchange system showed that the trimannosyl core backbone is substituted by an alpha-galactose. A comparison between the lipid constituent of the glycosylphosphatidylinositol anchor of several proteins and their spontaneous shedding by the action of an endogenous PI-PLC was made.
Assuntos
Antígenos de Protozoários/química , Glicoproteínas/química , Glicosilfosfatidilinositóis/química , Neuraminidase/química , Trypanosoma cruzi/química , Animais , Antígenos de Protozoários/efeitos dos fármacos , Antígenos de Protozoários/isolamento & purificação , Ceramidas/análise , Cromatografia por Troca Iônica/métodos , Cromatografia em Camada Fina/métodos , Glicoproteínas/efeitos dos fármacos , Glicoproteínas/isolamento & purificação , Glicosilfosfatidilinositóis/isolamento & purificação , Concentração de Íons de Hidrogênio , Estágios do Ciclo de Vida/fisiologia , Neuraminidase/efeitos dos fármacos , Neuraminidase/isolamento & purificação , Fosfatidilinositol Diacilglicerol-Liase , Fosfoinositídeo Fosfolipase C , Trypanosoma cruzi/crescimento & desenvolvimento , Fosfolipases Tipo C/farmacologiaRESUMO
The human placental microvillar membrane contains several ectoenzymes, including 5'-nucleotidase, alkaline phosphatase and ATP-diphosphohydrolase (ATP-DPH), which might be involved in the extracellular metabolism of nucleotides. The type of anchorage to the plasma membrane of the two first enzymes has been shown to be via a glycosyl-phosphatidylinositol. In the present study, using an enzymatic approach, we show that the ATP-DPH should be attached to the plasma membrane through a different type of anchorage. We were also interested in the search of compounds which could interact differentially with this enzyme to be used as a tool for studying the other two hydrolytic enzymes in the presence of ATP-DPH. Here we report several inhibitors of ecto-ATPases which seem to be a useful tool for studying these three enzymes.
Assuntos
5'-Nucleotidase/análise , Fosfatase Alcalina/análise , Apirase/análise , Inibidores Enzimáticos/farmacologia , Placenta/enzimologia , 5'-Nucleotidase/metabolismo , Fosfatase Alcalina/metabolismo , Amitriptilina/farmacologia , Apirase/antagonistas & inibidores , Apirase/metabolismo , Cafeína/farmacologia , Membrana Celular/efeitos dos fármacos , Membrana Celular/enzimologia , Membrana Celular/ultraestrutura , Endopeptidases/farmacologia , Feminino , Flufenazina/farmacologia , Glicosilfosfatidilinositóis/metabolismo , Humanos , Lidocaína/farmacologia , Microvilosidades/efeitos dos fármacos , Microvilosidades/enzimologia , Microvilosidades/ultraestrutura , Nucleotídeos/metabolismo , Fosfatidilinositol Diacilglicerol-Liase , Fosfolipase D/farmacologia , Placenta/efeitos dos fármacos , Placenta/ultraestrutura , Fosfolipases Tipo C/farmacologiaRESUMO
Estudos prévios demonstraram que o comprometimento da produçäo de EDRF/NO mediada por receptores, após isquemia global e reperfusäo, possa ser devido a uma disfunçäo de G-proteínas que liga os receptores da célula endotelial à via da síntese de EDRF/NO. O presente trabalho experimental sugere que a criocardioplegia cristalóide, associada a hipotermia tópica, previne ou pode reverter, em parte, a disfunçäo endotelial nas mesmas condiçöes. Mais estudos seräo necessários para conclusöes mais definitivas, pois as análises estatísticas mais acuradas sugeriram aumento da amostragem. Este detalhe talvez seja devido às grandes dificuldades de uniformizaçäo relacionada a este tipo de experimentos. Além disso, demonstrou-se pela primeira vez que a hipotermia, por si só, pode estimular a liberaçäo de EDRF/NO pelo endotélio vascular. Isto sugere que o endotélio possa ser um importante sensor de mudanças da temperatura sangüínea e tem importantes implicaçöes para o entendimento da fisiologia da CEC e dos mecanismos locais de auto-regulaçäo.
Assuntos
Animais , Masculino , Feminino , Cães , Acetilcolina/farmacologia , Difosfato de Adenosina/farmacologia , Vasos Coronários/efeitos dos fármacos , Endotélio Vascular , Circulação Extracorpórea , Fluoreto de Sódio/farmacologia , Hipotermia Induzida , Ionóforos/farmacologia , Isoproterenol/farmacologia , Isquemia Miocárdica , Reperfusão Miocárdica , Nitroprussiato/farmacologia , Parada Cardíaca Induzida/métodos , Soluções Cardioplégicas/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Fosfolipases Tipo C/farmacologia , Relação Dose-Resposta a Droga , RelaxamentoRESUMO
O presente ensaio experimental estudou o efeito da infusao de soluçao cardioplégica cristalóide a altas pressoes sobre a funçao endotelial de artérias epicárdicas de caes. Nao se encontraram alteraçoes a nível de receptores (curvas dose-respostas à ACH e ADP; da transduçao do sinal iniciado nos receptores/sitema de G-proteínas (fluoreto de sódio) e nos processos intracelulares da produçao de EDRF/NO (fosfolipase C e ionóforo do cálcio A23187). A funçao da musculatura lisa vascular nao foi afetada quando se analisaram as respostas relaxantes (nitroprussiato de sódio e isoproterenol) e contráteis (KCI e prostaglandina 2alfa). Estes achados permitem as seguintes consideraçoes especulativas: a) O barotrauma produzido pela infusao da cardioplegia cristalóide a altas pressoes ocorreria apenas em circulaçoes coronarianas previamente doentes? b) Uma vez que as infusoes duraram de 2 a 3 minutos, seria o barotrauma coronariano um fenômeno dependente do tempo de infusao? c) Para que ocorra o barotrauma seriam necessários níveis mais elevados de Potássio? d) Questionara existência do fenômeno do barotrauma coronariano produzido pela infusao de soluçoes cadioplégicas pelo menos nas condiçoes experimentais utilizadas. e) A metodologia empregada estuda apenas as reatividades vasculares de artérias coronarias epicárdicas. estas artérias seriam menos sensíveis aos efeitos da pressao de infusao da cardioplegia do que a microcirculaçao coronariana? f) Seria a circulaçao coronária do cao menos sensível a altas pressoes do que do homem? Estas observaçoes experimentais sugerem que a infusao de cardioplegia cristalóide, moderadamente hipocalêmica, a altas pressoes em um tempo de 2 a 3 minutos, nao interfere com a produçao de EDRF/NO pelo endotélio de coronárias epicárdicas do cao.
Assuntos
Animais , Cães , Barotrauma , Vasos Coronários/efeitos dos fármacos , Endotélio Vascular/efeitos dos fármacos , Parada Cardíaca Induzida/métodos , Pericárdio/efeitos dos fármacos , Soluções Cardioplégicas/farmacologia , Acetilcolina/farmacologia , Difosfato de Adenosina/farmacologia , Cálcio/farmacologia , Cloreto de Potássio/farmacologia , Dinoprosta/farmacologia , Endotélio Vascular/fisiologia , Fatores Relaxantes Dependentes do Endotélio , Fluoreto de Sódio/farmacologia , Ionóforos/farmacologia , Isoproterenol/farmacologia , Óxido Nítrico , Nitroprussiato/farmacologia , Pericárdio/lesões , Pressão/efeitos adversos , Fosfolipases Tipo C/farmacologiaRESUMO
On one hand, it has been demonstrated that the exposure of rat brain slices containing caudate putamen and accumbens nuclei to alpha-MSH brings about an increase in cAMP. This increase is affected when dopamine is present in the incubation medium. On the other hand, an interaction of melanotropinergic-like peptides with acetylcholinergic drugs has been showed to be similar to the one observed with dopamine. In this study we have intended to measure cGMP or IP3 in response to alpha-MSH, and also to study the interaction with cholinergic drugs by measuring the second messengers recently mentioned. cGMP and IP3 have been measured in tissues and medium in their response to the effect of alpha-MSH alone or in the presence of the peptide plus pilocarpine (selective muscarinic agonist) or atropine (selective muscarinic antagonist). None of them modified the cGMP levels when compared with the control group. The exposure of rat brain slices containing CP and Acc nuclei to alpha-MSH resulted in an increase in IP3 levels. Pilocarpine by itself brought about an increase of IP3 only when the highest doses was used. Atropine did not modify the IP3 content. However, when slices were exposured to both alpha-MSH and pilocarpine, IP3 content was similar to control values. The blockage of the muscarinic receptor with atropine blocked the IP3 increase induced by alpha-MSH as well. Therefore, we assume that alpha-MSH does not induce changes in cGMP but it does change the IP3 levels, probably acting at the muscarinic receptor level.
Assuntos
Atropina/farmacologia , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , GMP Cíclico/farmacocinética , Inositol 1,4,5-Trifosfato/farmacocinética , Agonistas Muscarínicos/farmacologia , Antagonistas Muscarínicos/farmacologia , Pilocarpina/farmacologia , Fosfolipases Tipo C/farmacologia , alfa-MSH/farmacologia , Animais , Técnicas In Vitro , Masculino , Ratos , Ratos WistarRESUMO
On one hand, it has been demonstrated that the exposure of rat brain slices containing caudate putamen and accumbens nuclei to alpha-MSH brings about an increase in cAMP. This increase is affected when dopamine is present in the incubation medium. On the other hand, an interaction of melanotropinergic-like peptides with acetylcholinergic drugs has been showed to be similar to the one observed with dopamine. In this study we have intended to measure cGMP Or IP3 in response to alpha-MSH, and also to study the interaction with cholinergic drugs by measuring the second messengers recently mentioned. cGMP and IP3 have been measured in tissues and medium in their response to the effect of alpha-MSH alone or in the presence of the peptide plus pilocarpine (selective muscarinic agonist) or atropine (selective muscarinic antagonist). None of them modified the cGMP levels when compared with lhe control group. The exposure of rat brain slices containing CP and Acc nuclei to alpha-MSH resulted in an increase in IP3 levels. Pilocarpine by itself brought about an increase of IP3 only when the highest doses was used. Atropine did not modify the IP3 content. However, when slices were exposured to both alpha-MSH and pilocarpine, IP3 content was similar to control values. The blockage of the muscarinic receptor with atropine blocked the IP3 increase induced by alpha-MSH as well. Therefore, we assume that alpha-MSH does not induce changes in cGMP but it does change the IP3 levels, probably acting at the muscarinic receptor level. (AU)
Assuntos
Ratos , Animais , Masculino , alfa-MSH/farmacologia , Pilocarpina/farmacologia , Atropina/farmacologia , Inositol 1,4,5-Trifosfato/farmacocinética , GMP Cíclico/farmacocinética , Cérebro/efeitos dos fármacos , Fosfolipases Tipo C/farmacologia , Ratos WistarRESUMO
On one hand, it has been demonstrated that the exposure of rat brain slices containing caudate putamen and accumbens nuclei to alpha-MSH brings about an increase in cAMP. This increase is affected when dopamine is present in the incubation medium. On the other hand, an interaction of melanotropinergic-like peptides with acetylcholinergic drugs has been showed to be similar to the one observed with dopamine. In this study we have intended to measure cGMP Or IP3 in response to alpha-MSH, and also to study the interaction with cholinergic drugs by measuring the second messengers recently mentioned. cGMP and IP3 have been measured in tissues and medium in their response to the effect of alpha-MSH alone or in the presence of the peptide plus pilocarpine (selective muscarinic agonist) or atropine (selective muscarinic antagonist). None of them modified the cGMP levels when compared with lhe control group. The exposure of rat brain slices containing CP and Acc nuclei to alpha-MSH resulted in an increase in IP3 levels. Pilocarpine by itself brought about an increase of IP3 only when the highest doses was used. Atropine did not modify the IP3 content. However, when slices were exposured to both alpha-MSH and pilocarpine, IP3 content was similar to control values. The blockage of the muscarinic receptor with atropine blocked the IP3 increase induced by alpha-MSH as well. Therefore, we assume that alpha-MSH does not induce changes in cGMP but it does change the IP3 levels, probably acting at the muscarinic receptor level.
Assuntos
Ratos , Animais , Masculino , alfa-MSH/farmacologia , Atropina/farmacologia , Encéfalo/efeitos dos fármacos , GMP Cíclico/farmacocinética , Inositol 1,4,5-Trifosfato/farmacocinética , Pilocarpina/farmacologia , Fosfolipases Tipo C/farmacologia , Ratos WistarRESUMO
The surface ionogenicity of five enteropathogenic Escherichia coli serogroups (O111:H2, O111:H12, O125:H9, O119:H6, and O26:H11) was investigated by electrokinetical approaches. All of the studied surfaces are negatively charged with their mean values of zeta potential (ZP) varying from -9.0 (O26:H11) to -11.9 mV (O111:H2). The populational behavior of the all bacteria are similar since very high ZP values varying from -26 to -30 mV were obtained in experiments carried out with the slip plane calculated at 6.83 nm from the cell surface. All the surfaces are extremely acidic, because the isoelectrophoretic points are localized at pH values below 3.0. Treatment of the microorganisms with neuraminidase did not alter their surface anionogenicity, while treatment with trypsin or phospholipase C reduced their negative charge.